Study: Using a diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing long COVID by 40%

Taking a two-week course of metformin, a safe and affordable diabetes medication after testing positive for SARS-CoV-2 leads to 40% fewer long COVID diagnoses over the following 10 months, compared to individuals taking a placebo, finds a new study published in The Lancet Infectious Diseases journal.